δ-casein Inhibitors
Chemical inhibitors of δ-casein function primarily by interfering with the pathways that lead to its secretion from cells. One such inhibitor is Thapsigargin, which targets the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), a pump responsible for maintaining low levels of cytosolic calcium by sequestering it within the endoplasmic reticulum. By inhibiting SERCA, Thapsigargin causes an increase in intracellular calcium, which paradoxically can disrupt normal calcium signaling and thus impede the secretion of calcium-sensitive proteins like δ-casein. Conversely, while calcium ionophores such as A23187, Ionomycin, and its brominated derivative BromoA23187, increase intracellular calcium levels, they bypass the controlled physiological release of calcium, potentially leading to dysregulation of calcium-sensitive processes including δ-casein secretion. The uncontrolled increase in calcium can desensitize the cellular machinery to calcium's signaling effects, thus hindering the normal secretion process.
Similarly, activators of protein kinase C (PKC) like Phorbol 12-myristate 13-acetate (PMA), 1,2-dioctanoyl-sn-glycerol (DOG), Phorbol 12,13-dibutyrate (PDBu), 4-β-Phorbol, 4α-Phorbol 12,13-didecanoate, 12-Deoxyphorbol 13-phenylacetate 20-acetate (DPPA), and 12-O-Tetradecanoylphorbol-13-acetate (TPA) can result in the overactivation of PKC. This overactivation can lead to the aberrant phosphorylation of downstream proteins, disrupting the delicate balance of signaling required for the proper secretion of δ-casein. The persistent activation of PKC can desensitize the pathway, as the cellular components become unresponsive to additional stimulation due to the hyperactive state, thus effectively inhibiting the secretion and release of δ-casein. Moreover, L-type calcium channel agonists like Bay K8644, while initially promoting an increase in calcium influx, can eventually lead to channel desensitization or the dysregulation of calcium homeostasis, further impacting δ-casein secretion. Through these mechanisms, each chemical can disrupt the normal secretory pathway of δ-casein, affecting its functional activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
The calcium ionophore A23187 directly increases intracellular calcium concentrations. Elevated calcium levels can lead to the activation of calcium-sensitive proteins and pathways, including those involved in the secretion process. Since δ-casein is a secreted protein, higher intracellular calcium can lead to its increased secretion, thereby functionally activating δ-casein by facilitating its transport and release from the cell. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA directly activates protein kinase C (PKC). PKC in turn can phosphorylate proteins related to vesicular trafficking and exocytosis. This phosphorylation can promote the secretion of proteins such as δ-casein, hence functionally activating δ-casein through enhanced secretion. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. Elevated cytosolic calcium can activate pathways that promote the secretion of δ-casein, thus functionally activating the protein by increasing its extracellular presence. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that selectively transports calcium across cell membranes, thereby increasing intracellular calcium concentration. The increase in calcium can activate δ-casein by triggering the secretory pathway and resulting in the release of δ-casein from the cells. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K8644 acts as a calcium channel agonist, specifically activating L-type calcium channels, leading to an increase in intracellular calcium. This increase can stimulate the secretion of proteins such as δ-casein, thus functionally activating δ-casein. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DOG is a synthetic analog of diacylglycerol (DAG) which activates protein kinase C (PKC). PKC activation can enhance the secretion of proteins, including δ-casein, thereby functionally activating δ-casein through its release into the extracellular space. | ||||||
Phorbol-12,13-dibutyrate | 37558-16-0 | sc-202285 | 1 mg | $124.00 | 3 | |
PDBu is a phorbol ester that acts as a PKC activator. By activating PKC, PDBu can influence cellular pathways involved in the secretion of proteins. This can lead to the functional activation of δ-casein as it is secreted from the cell. | ||||||
Phorbol | 17673-25-5 | sc-253267 | 5 mg | $270.00 | 1 | |
4-β-Phorbol is another phorbol ester that activates PKC. Active PKC can phosphorylate downstream targets that regulate protein secretion, thereby functionally activating δ-casein through its enhanced secretion. | ||||||
4α-Phorbol 12,13-didecanoate | 27536-56-7 | sc-201210 sc-201210A | 1 mg 5 mg | $188.00 $676.00 | 3 | |
4α-Phorbol 12,13-didecanoate is a PKC activator that can increase the secretion of proteins like δ-casein from cells, functionally activating δ-casein through secretion. | ||||||